Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer

Yi‐Long Wu, Masahiro Tsuboi, Jie He, +20

New England Journal of Medicine

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin‐Yuan Shih, +20

Proceedings of the National Academy of Sciences

Harbors Met AmplificationEngineeringPathologyTumor BiologyOncology +16

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Jean‐Charles Soria, Daniel S.W. Tan, Rita Chiari, +18

The Lancet

MedicineBronchial NeoplasmAdvanced AlkFirst-line CeritinibCancer Treatment +6

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

James Chih‐Hsin Yang, Lecia V. Sequist, Sarayut Lucien Geater, +10

The Lancet Oncology

Lux-lung 6MedicinePathologyClinical ActivityCancer Genomics +9

Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia

Guangchang Pei, Zhiguo Zhang, Jing Peng, +9

Journal of the American Society of Nephrology

MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

Sung‐Liang Yu, Hsuan‐Yu Chen, Gee‐Chen Chang, +20

Cancer Cell

MedicinePathologyCancer GenomicsSmall RnaLung Cancer +3

Value of sonography in determining the nature of pleural effusion: analysis of 320 cases.

Pan‐Chyr Yang, K T Luh, D B Chang, +3

American Journal of Roentgenology

Pleural BiopsyImaging AnatomyPleural EffusionsMedical UltrasoundMedical Imaging +12

<i>Mycobacterium abscessus</i>Complex Infections in Humans

Meng‐Rui Lee, Wang‐Huei Sheng, Chien‐Ching Hung, +3

Emerging infectious diseases

M. Abscessus SubspPathogenic MicrobiologyAntibiotic AdjuvantPathologyAntimicrobial Chemotherapy +20

Detection and Dynamic Changes of <i>EGFR</i> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

Tony Mok, Yi‐Long Wu, Jin Soo Lee, +17

Clinical Cancer Research

Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung Cancer

Jenn‐Yu Wu, Chong‐Jen Yu, Yeun‐Chung Chang, +3

Clinical Cancer Research